Skip to main content

Day: March 26, 2025

Nano Dimension Outlines Strategic Vision Following Desktop Metal Merger Ruling

Waltham, Mass, March 26, 2025 (GLOBE NEWSWIRE) —   Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today provided an update following the Delaware Court of Chancery’s March 24, 2025 ruling, which upheld Nano Dimension’s obligation to complete the acquisition of Desktop Metal, Inc. (NYSE: DM) per the parties’ July 2, 2024 Merger Agreement. Strategic Focus and Integration Planning Since the recomposition of the Nano Dimension Board on December 15, 2024, the Company has diligently prepared for the integration of Desktop Metal, despite ongoing litigation. These proactive efforts position Nano Dimension to maximize the combined entity’s potential. Nano Dimension’s strategic objective (outlined in our January 28, 2025 shareholder letter) is to become the preeminent...

Continue reading

Silynxcom Announces New Order from a National Police Agency in a European Country as Part of up to $2 Million Multi-Year Contract

New Order Strengthens Company’s European Market Penetration; Company Strategically Positioned to Meet the Growing Demand for Tactical Communications Equipment Netanya, Israel, March 26, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced that it has received a new order from a national police agency in a European country for the Company’s advanced in-ear communication systems. This order is part of an up to $2 million existing multi-year framework contract with the agency, which was originally announced in December 2024. The order is for Silynxcom’s new-generation Tetra-compatible, high-noise protection Clarus systems, combined with the Company’s “talking...

Continue reading

Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider

Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published by Zelluna ASA (the “Company”) published on 26 March 2025 regarding the resolution by the Company’s board of directors to carry out a share capital increase of NOK 0.70 through the issuance of seven (7) new shares in the Company in order to achieve a desirable ratio for the reverse share split. The Company has received the following notification of a transaction made by a close associate of a primary insider:Radforsk Investeringsstiftelse, a close associate of chair of the board of directors and primary insider of the Company, Anders Tuv, has today subscribed for seven (7) new shares in the Company at a subscription price of NOK 2.60 (equal to the price per share in the recently completed business combination and private placement)....

Continue reading

The TSX Celebrates the 30 Years Listing Anniversary of Globex Mining Enterprises Inc.

ROUYN-NORANDA, Quebec, March 26, 2025 (GLOBE NEWSWIRE) — Yesterday, the Toronto Stock Exchange surprised the Globex Team with this announcement posted on the TSX building downtown in the City of Toronto. Globex Mining Enterprises Inc. (GMX-TSX) was originally listed on the Montreal Stock Exchange in January of 1988 and transferred from the Montreal Stock Exchange upon it’s ceasing to list companies to the senior Toronto Stock Exchange in 1995 and has been there ever since as Globex’s primary listing. Globex is also listed on ten German trading platforms including Frankfurt, Munich, Berlin, Stuttgart, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Dusseldorf, and Quotrix Dusseldorf under symbol G1MN. In the U.S.A Globex is listed on the OTCQX International Exchange with the trading symbol GLBXF.     Foreign Private...

Continue reading

Satellogic Finalizes Move to U.S. Jurisdiction to Strengthen Market Position and Investor Access

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — On March 26, 2025, Satellogic Inc. (NASDAQ: SATL) (the “Company”), consummated its previously announced domestication, pursuant to which the Company changed its jurisdiction of incorporation, domesticating as a corporation incorporated under the laws of the State of Delaware and discontinuing as a business company with limited liability incorporated under the laws of the British Virgin Islands. The Company’s business, assets and liabilities on a consolidated basis, as well as its Board of Directors, the Company’s executive officers, principal business locations (other than its principal executive office) and fiscal year, were the same immediately after the domestication as they were immediately prior to the domestication. Additionally, the Company’s Class A common stock will continue...

Continue reading

Invesco Ltd: Form 8.3 – NIOX Group PLC; Public dealing disclosure

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree NIOX Group plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that the Company will be presenting three posters at the 2025 American Association for Cancer Research (AACR) Annual Meeting taking place from April 25th – 30th at McCormick Place Convention Center, Chicago, IL. The details are listed below. The abstracts will be published in the online Proceedings of the AACR. Poster 1: Title: Bria-ABC1 vs physician choice in late-stage MBC; early biomarker correlates of the randomized registration trialSession Title: Late-Breaking Research: Clinical Research 4Session Date and Time: 4/30/2025 9:00 AM –...

Continue reading

OSS Announces Order from Innovative Medical Imaging OEM

Current contract valued at approximately $500,000 with expected follow-on production orders valued at over $25 million over the next five years ESCONDIDO, Calif., March 26, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced a new $500,000 contract from a medical imaging OEM customer that is expected to contribute to revenue throughout 2025. Under the terms of the contract, OSS will provide 4U, short-depth-server (SDS) running Enterprise Class NVIDIA GPUs to support a customer’s innovative, FDA cleared, medical imaging technology for Breast Scanning. After this initial order, OSS expects follow-on orders from this medical OEM for next-generation liquid-cooled...

Continue reading

National Healthcare Properties Announces Preferred Stock Dividends

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, NHP declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock payable on April 15, 2025 to holders of record at the close of business on April 4, 2025. In addition, NHP declared a dividend of $0.4453125 per share on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock payable on April 15, 2025 to holders of record at the close of business on April 4, 2025. About National Healthcare Properties, Inc. National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) is a publicly registered real estate investment trust focused on acquiring a diversified...

Continue reading

Zelluna ASA [ZLNA]: Share capital increase resolution

Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published on 9 January 2025 regarding an extraordinary general meeting held in Zelluna ASA (the “Company“), where it was resolved to carry out a reverse share split in the ratio 10:1 and to grant the Company’s board of directors a general authorisation to issue shares. As the Company’s shares cannot be fully divided by 10, the Company’s board of directors has today resolved a share capital increase of NOK 0.70 through the issuance of seven (7) new shares, each with a par value of NOK 0.10, and a subscription price of NOK 2.60 per share. The shares were subscribed for by Radforsk Investeringsstiftelse. A separate notification regarding transaction by persons discharging managerial responsibilities (PDMRs) will be published shortly....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.